mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
Nutlin-3 |
CCLE |
pan-cancer |
AAC |
0.019 |
0.7 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.7 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.021 |
0.7 |
mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.7 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.7 |